Abstract Original Article
studied and present higher mortality; however, nononcological diseases are more frequent and have greater survival, with the same needs as oncological ones. [5, [9] [10] [11] There is an increase number of patients with advanced chronic diseases who attend to emergency services, producing bed saturation, prolonged hospital stay, even in intensive care rooms and high rates of in-hospital death, often in inadequate conditions. However, there are no adequate reports worldwide. [2, [10] [11] [12] [13] [14] [15] In Latin America, there is a few data on this subject and a lack of knowledge about palliative care, with worse situation in urban tertiary hospitals, coupled with problems at the primary health care. In Peru, the situation is similar, and the main social security hospitals are almost collapsed due to patient overload, many of them with terminal illnesses. [13, 14] We set as objectives: To determine the proportion of terminal illness in patients readmitted to emergency room, to evaluate the use frequency of this service and the rate of death in terminal patients.
subjects and Methods
A cross-sectional study took place between May 15 and 21 of 2016. Included 18-year-old patients or older who were readmitted to the emergency room of a tertiary hospital; psychiatry and obstetrics patients were excluded. Readmission was considered as to two or more admissions in the last year. This social security hospital had 1500 beds and 93 medical specialties, its adult emergency service had 120 stretchers and annually reports 160 thousand attentions and 22 thousand admissions. Patient and/or caregiver were interviewed; medical history was reviewed and made followed up by 1 year. For cancer was considered histologically confirmation, stage IV and multiple brain, lung, or liver metastases. Was considered as a nononcologic end stage disease: Total functional dependence (Katz index) or severe cognitive impairment (Pfeiffer questionnaire) in addition of advanced neurological disease, glomerular filtration rate <30%, Child-Pugh Stage C liver cirrhosis, permanent home oxygen therapy or Left ventricular ejection fraction <20%. To determinate significant difference for patients with terminal illness in the oncological and nononcological group were used Fisher exact test and U of Mann-Whitney test by two independent samples, considering a significant P < 0.05. Statistical program SPSS 21.00 (IBM, SPSS Stat 21) was used.
results
Of 349 admissions in the study week, 92 (26%) were readmissions. It was not possible to evaluate 13 cases (seven lost, four incomplete, one deceased, and one readmitted). Seventy-nine patients entered the study, 29 (36, 7%) were identifying with terminal disease. Eleven (38%) of them had cancer (breast two, prostate two, kidney two, endometrium one, hepatic one, pancreas one, lung one, and lymphoma one). Nononcologic terminal disease was identified in 18 cases (62%) (Stroke disability four, dementia three, renal failure three, liver cirrhosis two, pulmonary fibrosis two, heart failure one, sequelae of traumatic brain injury one, sequelae of meningitis one, and myelodysplasia one). Reasons for admission were encephalopathy 28%, respiratory failure 21%, and sepsis 14% (P > 0.05 for oncological and nononcological groups); more frequent symptoms were dyspnea 41%, mental confusion 24%, and pain 21%. Terminal patients had an average of 6.2 (standard deviation 8.2) emergency visits in the last year (range 2-46), being admitted 48.6% of these visits (P > 0.05 for oncological and nononcological groups). Table 1 presents characteristics according to oncological and nononcological groups, not finding significant differences (P > 0.05) and Figure 1 shows the mortality rate, with P < 0.05.
dIscussIon
The readmission rate was similar to 2012 for the same service. [13] More than 35% of patients readmitted to emergency suffer from the end-stage disease, similar to reports from Europe and North America; where there are better-structured health systems. The patients had inadequate control of symptoms, dyspnea predominated instead of pain, different from that reported in other countries. Age was similar in both groups, with female gender predominance in oncological and male gender in nononcological. Unlike reports from Europe and North America, genitourinary cancer 64% was the most frequent, with low frequency of lung cancer. [4, 9, 10, 16] Similar to international reports, chronic nononcologic illnesses were common, with frequent neurodegenerative involvement (50%) but a low frequency of cardiopulmonary disease compared to Glajchen et al. The varied pathology of this group makes identification and prognosis difficult, but produces greater symptomatology, functional dependence and cognitive impairment. [1, 17, 18] It is evidenced that terminal ill patients frequently use the emergency service, for consultations, admissions and also the shock-trauma unit, with more frequency of nononcological group. There is an extended stay in emergency, more than 3 days on average, this being higher than international reports (where it is <24 h). This is due to deficiencies in the health system, more at the primary level of care. [10] The mortality of emergency terminal patients was high, dying often in inadequate conditions for the patient and the family. The cancer group has the highest mortality and the highest survival rate for noncancer patients is in agreement with the poor prediction reported. The lack of clear legislation for end-of-life situations (anticipated will or nonresuscitation order) and the poor training of health personnel on this issue contribute to prolonged agony and suffering. The application of multidisciplinary palliative care is necessary. [9, 10, 14, 17] The ethical conflict for cataloguing the patient as a terminal still persists, but its purpose is to provide better care and quality of life. Limiting factors are sample size, selection period, and establishment evaluated, and selection criteria in noncancer patients are also questionable. However, the study shows the existing reality, poorly studied in Latin America, and suggests further research, especially in advanced nononcologic disease.
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